DUBLIN, Ohio, Dec. 2 /PRNewswire-FirstCall/ -- Cardinal Health today announced that Carrie Cox will serve on the company's board of directors, effective immediately.
Cox, 52, most recently served as executive vice president and president of global pharmaceuticals at Schering-Plough Corp. She completed her tenure with the company at the close of its merger with Merck last month.
Prior to her term at Schering-Plough, Cox served as president of Pharmacia Corp.'s global pharmaceutical business. She had joined Pharmacia's predecessor company, Pharmacia & Upjohn, in 1997 and held a number of positions of increasing responsibility there.
"Carrie brings an extraordinary range of experiences from her 30 years in biopharmaceuticals and health care," said George S. Barrett, chairman and chief executive officer of Cardinal Health. "We are very excited to be able to draw on her perspectives and insights as we continue to execute on our strategic vision."
Cox has received numerous industry awards, and FORTUNE magazine named her to its list of the "50 Most Powerful Women in Business" on six separate occasions, including five consecutive years since 2005. She is a member of the board of directors of Texas Instruments, a member of the Health Policy and Management Executive Council at the Harvard School of Public Health and a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology.
Cox received a Bachelor of Science degree from the Massachusetts College of Pharmacy in 1981.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a Fortune 18 health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, h
|SOURCE Cardinal Health, Inc.|
Copyright©2009 PR Newswire.
All rights reserved